Granules India Ltd - 532482 - Board Of Directors Of Granules India Limited To Consider The Proposal Of Buyback Of Equity Shares
Board of Directors of Granules India Limited to consider the proposal of Buyback of Equity Shares16-01-2020
16-01-2020
GRANULES INDIA LTD.-$ - 532482 - Shareholding for the Period Ended December 31, 2019
Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here13-01-2020
Granules India says voluntarily' recalling Ranitidine tabs
Drug firm Granules India on Monday said it is voluntarily' recalling Ranitidine tablets used to treat ulcers of the stomach and intestines. Raniti13-01-2020
GRANULES INDIA LTD.-$ - 532482 - Clarification On News Item For Re-Call Of Ranitidine By Granules India Limited
Clarification on news item for re-call of Ranitidine by Granules India Limited13-01-2020
Granules India Ltd - 532482 - Board to consider Third Interim Dividend
Granules India Ltd has informed BSE that meeting of the Board of Directors of the Company is scheduled to be held on January 21, 2020, inter alia, to consider and approve the Un-audited Financial Results for the third quarter ended December 31, 2019 and the payment of third interim dividend for the FY 2019-20, if any. Further, Insider Trading Window of Granules India Limited shall remain closed till January 23, 2020 in view of the above mentioned Board Meeting.11-01-2020
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for Intimation Of Board Meeting
GRANULES INDIA LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2020 ,inter alia, to consider and approve Intimation of Board Meeting10-01-2020
GRANULES INDIA LTD.-$ - 532482 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0660 Name of the Signatory :- chaitanya tummalaDesignation :- Company Secretary and Compliance Officer10-01-2020
Granules India, Glenmark Pharma rally 3% on drug approvals from USFDA
Granules India got the nod for a painkiller, while Glenmark got it for Deferasirox tablets used in the treatment for chronic iron overload syndrome.07-01-2020
Granules India Ltd - 532482 - Closure of Trading Window
Intimation of Trading Window Closure30-12-2019
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Resignation of Director
Confirmation received from Mr. C. Parthasarathy, Resigning Director.27-12-2019